Effect of biliary obstruction on the hepatic excretion of imipenem-cilastatin
- PMID: 1416901
- PMCID: PMC192439
- DOI: 10.1128/AAC.36.9.2057
Effect of biliary obstruction on the hepatic excretion of imipenem-cilastatin
Abstract
The biliary excretion of imipenem-cilastatin studied by endoscopic cannulation of the common bile duct in patients with complete obstruction and in a group without obstruction showed that despite a 24-h prophylaxis, the bile obtained from patients with obstruction immediately after cannulation contained neither imipenem nor cilastatin, while there were 2 and 5% of peak concentrations in serum for imipenem and cilastatin, respectively, in the bile from patients without obstruction. Biliary excretion of both compounds increased rapidly after decompression, reaching a maximum of 15% of peak levels in serum within 2 h. Twenty-four hours after drainage, the biliary excretion of the drugs further improved. We conclude that since biliary obstruction impairs excretion of antibiotics, drainage is necessary for the control of sepsis in obstructed cholangitis.
Similar articles
-
The effect of obstruction on the biliary excretion of cefoperazone and ceftazidime.J Antimicrob Chemother. 1990 Mar;25(3):399-406. doi: 10.1093/jac/25.3.399. J Antimicrob Chemother. 1990. PMID: 2187012
-
Bile levels of imipenem in patients with T-drain following the administration of imipenem/cilastatin.Infection. 1988 Jul-Aug;16(4):225-8. doi: 10.1007/BF01650757. Infection. 1988. PMID: 3182087
-
Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulation.Diagn Microbiol Infect Dis. 2010 Nov;68(3):251-8. doi: 10.1016/j.diagmicrobio.2010.06.012. Epub 2010 Sep 18. Diagn Microbiol Infect Dis. 2010. PMID: 20851549 Clinical Trial.
-
Pharmacokinetics of parenteral imipenem/cilastatin in patients on continuous ambulatory peritoneal dialysis.J Antimicrob Chemother. 1991 Feb;27(2):225-32. doi: 10.1093/jac/27.2.225. J Antimicrob Chemother. 1991. PMID: 2055813
-
Imipenem/cilastatin: evolution of the sustained-release intramuscular formulation.Chemotherapy. 1991;37 Suppl 2:21-5. doi: 10.1159/000238915. Chemotherapy. 1991. PMID: 1879183 Clinical Trial.
Cited by
-
Antimicrobial therapy for acute cholangitis: Tokyo Guidelines.J Hepatobiliary Pancreat Surg. 2007;14(1):59-67. doi: 10.1007/s00534-006-1157-6. Epub 2007 Jan 30. J Hepatobiliary Pancreat Surg. 2007. PMID: 17252298 Free PMC article.
-
Pharmacokinetics and clinical study of cefotetan in bile: prophylactic use in biliary tract surgery.Pharm World Sci. 1993 Apr 23;15(2):79-82. doi: 10.1007/BF01874087. Pharm World Sci. 1993. PMID: 8490588
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources